GRHL2 and ovarian carcinoma: DNase sensitivity, FAIRE, ATAC-seq, or chromatin capture assays coupled with GRHL2 ChIP experiments will be useful to examine the interplay of GRHL2 and chromatin accessibility of epithelial genes in ovarian carcinoma cells with an intermediate or a full EMT phenotype.